Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice

Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice

Shank2 is an excitatory postsynaptic scaffolding protein strongly implicated in autism spectrum disorders (ASDs). Shank2-mutant mice with a homozygous deletion of exons 6 and 7 (Shank2-KO mice) show decreased NMDA receptor (NMDAR) function and autistic-like behaviors at juvenile [∼postnatal day (P21...

Full description

Bibliographic Details
Main Authors:	Ye-Eun Yoo, Seungjoon Lee, Woohyun Kim, Hyosang Kim, Changuk Chung, Seungmin Ha, Jinsu Park, Yeonseung Chung, Hyojin Kang, Eunjoon Kim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	autism spectrum disorders Shank2 NMDA receptor memantine RNA-Seq synapse
Online Access:	https://www.frontiersin.org/articles/10.3389/fnmol.2021.712576/full

Similar Items

Gene Dosage- and Age-Dependent Differential Transcriptomic Changes in the Prefrontal Cortex of Shank2-Mutant Mice
by: Seungjoon Lee, et al.
Published: (2021-06-01)

Dietary Zinc Supplementation Prevents Autism Related Behaviors and Striatal Synaptic Dysfunction in Shank3 Exon 13–16 Mutant Mice
by: Chantelle Fourie, et al.
Published: (2018-10-01)

Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit
by: Jiseok eLee, et al.
Published: (2015-03-01)

Memantine: Reality and Potentiality
by: Rodolfo M. Antonello, et al.
Published: (2008-01-01)

Shank3 Mice Carrying the Human Q321R Mutation Display Enhanced Self-Grooming, Abnormal Electroencephalogram Patterns, and Suppressed Neuronal Excitability and Seizure Susceptibility
by: Ye-Eun Yoo, et al.
Published: (2019-06-01)

Editorial: Shankopathies: Shank Protein Deficiency-Induced Synaptic Diseases
by: Elodie Ey, et al.
Published: (2020-02-01)

Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling
by: Yeunkum Lee, et al.
Published: (2017-06-01)

GABA Neuronal Deletion of Shank3 Exons 14–16 in Mice Suppresses Striatal Excitatory Synaptic Input and Induces Social and Locomotor Abnormalities
by: Taesun Yoo, et al.
Published: (2018-10-01)

Evidence That Memantine Reduces Chronic Tinnitus Caused By Acoustic Trauma In Rats
by: Yiwen eZheng, et al.
Published: (2012-08-01)

Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors
by: Jaeseung eKang, et al.
Published: (2015-05-01)

Shank2 Deletion in Parvalbumin Neurons Leads to Moderate Hyperactivity, Enhanced Self-Grooming and Suppressed Seizure Susceptibility in Mice
by: Seungjoon Lee, et al.
Published: (2018-06-01)

Identification of a novel Shank2 transcriptional variant in Shank2 knockout mouse model of autism spectrum disorder
by: Yong-Seok Lee, et al.
Published: (2020-04-01)

Shank3 Exons 14–16 Deletion in Glutamatergic Neurons Leads to Social and Repetitive Behavioral Deficits Associated With Increased Cortical Layer 2/3 Neuronal Excitability
by: Taesun Yoo, et al.
Published: (2019-10-01)

Management of moderate to severe Alzheimer’s disease: Focus on memantine
by: Evangelyn Dominguez, et al.
Published: (2011-12-01)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
by: Naser Osanloo, et al.
Published: (2015-10-01)

Memantine Enhances the Effect of Olanzapine in Patients With Schizophrenia: A Randomized, Placebo-Controlled Study
by: Ahmad Fakhri, et al.
Published: (2016-12-01)

Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats
by: Ziphozethu Ndlazi, et al.
Published: (2018-09-01)

Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models
by: Christopher Heise, et al.
Published: (2018-06-01)

Differentially altered social dominance- and cooperative-like behaviors in Shank2- and Shank3-mutant mice
by: Kyung Ah Han, et al.
Published: (2020-10-01)

Transcriptome analysis of Shank3-overexpressing mice reveals unique molecular changes in the hypothalamus
by: Chunmei Jin, et al.
Published: (2018-11-01)

The Neomycin Resistance Cassette in the Targeted Allele of Shank3B Knock-Out Mice Has Potential Off-Target Effects to Produce an Unusual Shank3 Isoform
by: Chunmei Jin, et al.
Published: (2021-01-01)

In vitro zinc supplementation alters synaptic deficits caused by autism spectrum disorder-associated Shank2 point mutations in hippocampal neurons
by: Yukti Vyas, et al.
Published: (2021-06-01)

Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan
by: Takashi Matsumoto, et al.
Published: (2018-12-01)

Effects of memantine on the excitation-inhibition balance in prefrontal cortex
by: Nadezhda V. Povysheva, et al.
Published: (2016-12-01)

Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice
by: Yukti Vyas, et al.
Published: (2020-08-01)

Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal–CA1 projection
by: Peng Li, et al.
Published: (2021-06-01)

Die neuroprotektive Wirkung der NMDA-Rezeptorantagonisten CGS, Memantin und Ifenprodil, sowie Roscovitin und NMDA auf die hypoxiebedingte Zellschädigung an embryonalen kortikalen Zellen von Ratten
by: Holtkamp, Johanna
Published: (2015)

Crystal structure of memantine–carboxyborane
by: Theppawut I. Ayudhya, et al.
Published: (2019-05-01)

Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line
by: Ayako Kumagai, et al.
Published: (2014-12-01)

Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
by: Tetsuro Kikuchi
Published: (2020-07-01)

Transcriptome analyses suggest minimal effects of Shank3 dosage on directional gene expression changes in the mouse striatum
by: Yeunkum Lee, et al.
Published: (2019-07-01)

by: Rita Moretti, et al.
Published: (2008-05-01)

Unexpected Compensatory Increase in Shank3 Transcripts in Shank3 Knock-Out Mice Having Partial Deletions of Exons
by: Chunmei Jin, et al.
Published: (2019-09-01)

Distinct Phenotypes of Shank2 Mouse Models Reflect Neuropsychiatric Spectrum Disorders of Human Patients With SHANK2 Variants
by: Ahmed Eltokhi, et al.
Published: (2018-07-01)

The Shank3 interaction partner ProSAPiP1 regulates postsynaptic SPAR levels and the maturation of dendritic spines in hippocampal neurons
by: Dominik eReim, et al.
Published: (2016-05-01)

Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold
by: Hof Patrick R, et al.
Published: (2011-09-01)

A Comparative Study of the Prescription of Memantine and Piracetam in Poststroke Aphasia
by: Fariborz Khorvash, et al.
Published: (2015-12-01)

Increased ribosomal protein levels and protein synthesis in the striatal synaptosome of Shank3-overexpressing transgenic mice
by: Chunmei Jin, et al.
Published: (2021-02-01)

Memantine: procognitive and antinegative effects in mental illness (a literature review)
by: D. V. Romanov, et al.
Published: (2020-06-01)

Autism-associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses
by: Michael Bucher, et al.
Published: (2021-05-01)